AMPH – amphastar pharmaceuticals, inc. (US:NASDAQ)

News

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
Amphastar Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol [Yahoo! Finance]
Amphastar Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol
Amphastar Pharmaceuticals: Profitable Pharma With Strong Growth [Seeking Alpha]
Reassessing Amphastar Pharmaceuticals [Seeking Alpha]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com